Share
EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia
LEUKEMIA
Young, E; Noerenberg, D; Mansouri, L; Ljungstrom, V; Frick, M; Sutton, LA; Blakemore, SJ; Galan-Sousa, J; Plevova, K; Baliakas, P; Rossi, D; Clifford, R; Roos-Weil, D; Navrkalova, V; Dorken, B; Schmitt, CA; Smedby, KE; Juliusson, G; Giacopelli, B; Blachly, JS; Belessi, C; Panagiotidis, P; Chiorazzi, N; Davi, F; Langerak, AW; Oscier, D; Schuh, A; Gaidano, G; Ghia, P; Xu, W; Fan, L; Bernard, OA; Nguyen-Khac, F; Rassenti, L; Li, J; Kipps, TJ; Stamatopoulos, K; Pospisilova, S; Zenz, T; Oakes, CC; Strefford, JC; Rosenquist, R; Damm, F, 2017: EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia. LEUKEMIA 31(7), p. 1547 - 1554, doi: 10.1038/leu.2016.359
CEITEC authors: